News
CMS gives hospitals 14 weeks to start daily COVID, flu reports
The Centers for Medicare & Medicaid Services (CMS) will send letters on October 7 to all 6,200 hospitals that receive reimbursement from the...
News
‘Overwhelming evidence’ FDA’s opioid approval process is shoddy
The majority of approvals of opioids for the treatment of chronic pain during 1997-2018 were based on pivotal trials that lacked critical safety...
News
More U.S. states cap insulin cost, but activists will ‘fight harder’
Drugmakers and health insurers have not legally challenged state laws capping out-of-pocket insulin costs; still, such attempts to make insulin...
News
Petition seeks to oust AAD president-elect, citing private equity conflicts
It is the second time since fall 2019 that a petition has been used to question the conflicts of American Academy of Dermatology officials.
News
Convalescent plasma actions spark trial recruitment concerns
“It’s not clear that people with COVID-19, especially those who are severely ill and hospitalized, will choose to enlist in a clinical trial –...
News
Addiction specialist charged in $681 million treatment fraud case
Prosecutors allege that Dr. Michael Ligotti played a central role in a scheme in which Medicare and private insurers paid millions in fraudulent...
News
Move over supplements, here come medical foods
When it comes to medical foods, the FDA has often looked the other way because the ingredients may already have been proven safe and the danger to...
News
Big pharma sues to block Minnesota insulin affordability law
The state has estimated that as many as 30,000 Minnesotans would be eligible for free insulin in the first year of the program.
News
#WhiteCoats4BlackLives: A ‘platform for good’
Sporadic protests – with participants in scrubs or white coats kneeling for 8 minutes and 46 seconds in memory of George Floyd – have quickly...
News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
News
Ob.gyns., peds, other PCPs seeking COVID-19 financial relief from feds
A handful of specialties are calling for targeted relief payments from the federal government, saying that they have been left out of...
News
Private equity: Salvation or death sentence?
Depending on whom you ask, the continuing growth of private equity purchases of dermatology practices is either the death - or salvation - for the...
News
Sudden loss of taste and smell should be part of COVID-19 screen
These signs may be present in many with asymptomatic COVID-19, and therefore asking about them could be a way to prioritize people for initial...